Read More Pharma Industry News Trevi Therapeutics reports promising results for Oral Nalbuphine in human abuse potential study Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced positive oral nalbuphine results from its human abuse potential (HAP)… byPallavi MadhirajuDecember 4, 2024